Cargando…
A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1
BACKGROUND: Anti-angiogenic therapies, targeting VEGF, are a promising treatment for hepatocellular carcinoma (HCC). To enhance this potential therapy, identification of novel targets in this pathway is of major interest. Nitric oxide (NO) plays a crucial role in VEGF-dependent angiogenesis. NO prod...
Autores principales: | Buijs, Nikki, Oosterink, J. Efraim, Jessup, Morgan, Schierbeek, Henk, Stolz, Donna B., Houdijk, Alexander P., Geller, David A., van Leeuwen, Paul A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660142/ https://www.ncbi.nlm.nih.gov/pubmed/28741166 http://dx.doi.org/10.1007/s10456-017-9567-4 |
Ejemplares similares
-
Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis
por: Kostourou, V, et al.
Publicado: (2002) -
A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase
por: Ragavan, Vinitha N., et al.
Publicado: (2023) -
Dimethylarginine dimethylaminohydrolase 2 promotes tumor angiogenesis in lung adenocarcinoma
por: Shiozawa, Toshihiro, et al.
Publicado: (2015) -
Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis
por: Lange, Clemens, et al.
Publicado: (2016) -
Dimethylarginine dimethylaminohydrolase 1 is involved in spinal nociceptive plasticity
por: D'Mello, Richard, et al.
Publicado: (2015)